Observational studyNature cancer2023

Potent high-avidity neutralizing antibodies and T cell responses after COVID-19 vaccination in individuals with B cell lymphoma and multiple myeloma.

Andrea Keppler-Hafkemeyer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.